Workflow
Oriental Ocean(002086)
icon
Search documents
东方海洋(002086) - 关于持股5%以上股东减持股份实施情况的公告
2025-08-18 13:33
证券代码:002086 证券简称:东方海洋 公告编号:2025-041 山东东方海洋科技股份有限公司 关于持股 5%以上股东减持股份实施情况的公告 国元基金保证向本公司提供的信息内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 山东东方海洋科技股份有限公司(以下简称"公司")于 2025 年 5 月 12 日披露了《关于上市公司持股 5%以上股东减持股份预披露公告》(公告编号: 2025-025),公司持股 5%以上股份的大股东深圳前海国元私募证券基金管理有 限公司-国元价值精选一号私募证券投资基金(以下简称"国元基金")计划自 2025 年 6 月 5 日至 2025 年 9 月 4 日,以集中竞价方式减持公司股份 19,580,000 股(不超过上市公司总股本的 1%)。 公司近期收到国元基金出具的《关于减持股份实施情况的告知函》,截至目 前,国元基金通过集中竞价方式累计减持公司股份 19,580,000 股,本次减持计划 已实施完成。现将具体减持情况公告如下: 一、股东减持情况 | 股东名称 | 减持方式 | 减持 | | ...
东方海洋股价上涨2.46% 海洋经济政策推动产业布局
Sou Hu Cai Jing· 2025-08-15 15:13
Group 1 - The latest stock price of Dongfang Ocean is 2.92 yuan, an increase of 0.07 yuan from the previous trading day, with a trading volume of 393 million yuan [1] - The stock experienced a fluctuation of 7.02%, reaching a high of 2.99 yuan and a low of 2.79 yuan during the trading session [1] - Dongfang Ocean operates in the agriculture, animal husbandry, and fishery sector, focusing on aquaculture, processing, and the research and development of marine biological products [1] Group 2 - Recent national policies emphasize the promotion of high-quality development in the marine economy, specifically encouraging the cultivation of emerging industries such as marine biomedicine and the involvement of state-owned enterprises in marine resource development [1] - On August 15, Dongfang Ocean saw a net inflow of main funds amounting to 27.71 million yuan, with a cumulative net inflow of 8.77 million yuan over the past five days [2]
东方海洋(002086) - 简式权益变动报告书-国元基金
2025-08-11 12:32
山东东方海洋科技股份有限公司 简式权益变动报告书 签署日期: 二〇二五 年 八 月 上市公司:山东东方海洋科技股份有限公司 上市地点:深圳证券交易所 股票简称:东方海洋 股票代码: 002086.SZ 信息披露义务人:深圳前海国元私募证券基金管理有限公司(代表国元价 值精选一号私募证券投资基金) 住所/通讯地址:深圳市前海深港合作区前湾一路 1 号 A 栋 201 室 ( 入驻 深圳市前海商务秘书有限公司) 股份变动性质: 股份减少 信息披露义务人声明 本部分所述词语或简称与本报告书"释义"所述词语或简称具有相同含义。 一、本报告书系信息披露义务人依据《证券法》《收购办法》和《淮则 15 号》等法律、法规及规范性文件编制。 二、依据《证券法》《收购办法》和《准则 15 号》等法律法规的规定,本 报告书已全面披露信息披露义务人在山东东方海洋科技股份有限公司拥有权益 的股份;截至本报告书签署之日,除本报告书披露的持股信息外,上述信息披露 义务人没有通过任何其他方式在山东东方海洋科技股份有限公司拥有权益。 三、信息披露义务人签署本报告书已获得必要的授权和批准,其履行亦不违 反信息披露义务人的公司章程或内部规则中的任 ...
东方海洋(002086) - 关于持股5%以上股东权益变动后持股比例触及1%及5%整数倍的提示性公告
2025-08-11 12:32
山东东方海洋科技股份有限公司 关于持股 5%以上股东权益变动后持股比例触及 1%及 5% 整数倍的提示性公告 国元基金保证向本公司提供的信息内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 证券代码:002086 证券简称:东方海洋 公告编号:2025-040 2 | 按照《证券法》第 | | | --- | --- | | 六十三条的规定, | 是□ 否☑ | | 是否存在不得行使 | 如是,请说明对应股份数量及占现有上市公司股本的比例。 | | 表决权的股份 | | | 6.30%以上股东增持股份的说明(不适用) | | | 7.备查文件 | | | 1.中国证券登记结算有限责任公司持股变动明细 | □ | | 2.相关书面承诺文件 | □ | | 3.律师的书面意见 | □ | | 4.深交所要求的其他文件 | ☑ | 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 特别提示: 深圳前海国元私募证券基金管理有限公司-国元价值精选一号私募证券投 资基金(以下简称"国元基金")为持有山东东方海洋科技股份有限公司(以下 简称"公司")5%以上股份的大股东,国元基金于 2025 ...
A股渔业股快速拉升,中水渔业直线涨停
Ge Long Hui A P P· 2025-07-30 05:14
Group 1 - The A-share market saw a rapid increase in fishery stocks, with Zhongshui Fishery hitting the daily limit, and Guolian Aquatic rising over 6% [1] - Other companies such as Kaichuang International and Dahua Co. also experienced gains of over 3%, while Zangzi Island, Haodangjia, and Dongfang Ocean followed suit [1] Group 2 - Zhongshui Fishery (code: 000798) increased by 9.98% with a total market value of 3.227 billion and a year-to-date increase of 19.03% [2] - Guolian Aquatic (code: 300094) rose by 6.48% with a market value of 4.817 billion and a year-to-date increase of 12.66% [2] - Kaichuang International (code: 600097) saw a rise of 3.86% with a market value of 2.725 billion and a year-to-date increase of 12.42% [2] - Dahua Co. (code: 600257) increased by 3.30% with a market value of 2.714 billion and a year-to-date increase of 19.49% [2] - Zangzi Island (code: 002069) rose by 2.11% with a market value of 3.100 billion and a year-to-date increase of 18.80% [2] - Haodangjia (code: 600467) increased by 1.65% with a market value of 3.594 billion and a year-to-date increase of 6.94% [2] - Dongfang Ocean (code: 002086) saw a rise of 1.03% with a market value of 5.759 billion and a year-to-date increase of 1.73% [2] - The MACD golden cross signal has formed, indicating a positive trend for these stocks [1]
7月25日晚间重要公告一览
Xi Niu Cai Jing· 2025-07-25 11:30
Group 1 - Liu Pharmaceutical Group plans to repurchase shares worth between 100 million and 200 million yuan, with a maximum repurchase price of 25.70 yuan per share [1] - Dongshan Precision intends to invest up to 1 billion USD to build a high-end printed circuit board project to meet the long-term demand for high-end printed circuit boards in emerging scenarios such as AI [1] - Bomaike reported a net profit of 12.39 million yuan for the first half of the year, a year-on-year decline of 80.42% [2] Group 2 - Western Mining achieved a net profit of 1.869 billion yuan in the first half of the year, a year-on-year increase of 15% [2] - Fuliwang expects a net loss of approximately 17 million yuan for the first half of the year, a decrease of 137.12% compared to the same period last year [2] - Digital Certification anticipates a net loss of between 80 million and 96 million yuan for the first half of the year, compared to a loss of 29.25 million yuan in the same period last year [3] Group 3 - Shanghai Construction reported a net profit of 710 million yuan for the first half of the year, a year-on-year decrease of 14.04% [5] - Funneng Co. achieved a net profit of 1.337 billion yuan in the first half of the year, a year-on-year increase of 12.48% [6] - Tengda Construction's total contract amount for the first half of the year decreased by 17.55% year-on-year [7] Group 4 - Fudan Fuhua decided to terminate the public transfer of a 28% stake in a subsidiary due to the lack of a deposit from potential buyers [9] - Fulei Ant's subsidiary has decided to cease operations due to intense competition in the photovoltaic industry and ongoing losses [11] - Dongfang Ocean's subsidiary received a medical device registration certificate for a folic acid testing kit [14] Group 5 - Huayu Pharmaceutical's subsidiary received overseas listing approvals for several products [16] - Feima International received a performance commitment compensation of 437 million yuan from its controlling shareholder [16] - Guangshen Railway signed a cooperation agreement for the Guangzhou East Station renovation project with a total investment of approximately 16.66 billion yuan [16] Group 6 - Anhui Construction won the bid for the S68 Jingde to Jixi Expressway project with an estimated total investment of 5.7 billion yuan [18] - China Communications Construction Company signed new contracts worth 991.054 billion yuan in the first half of the year, a year-on-year increase of 3.14% [19] - Kehui Co. plans to use up to 70 million yuan of idle funds for cash management [22] Group 7 - Biological Shares' subsidiary received a clinical trial approval for a cat mRNA vaccine, the first of its kind in China [23] - Ruipu Biological received a clinical trial approval for a pig mRNA vaccine, which is the first economic animal mRNA vaccine in China [24] - Nanjing New Hundred's major assets were judicially frozen due to liquidity debt crisis faced by its controlling shareholder [27] Group 8 - Changshu Bank plans to merge three village banks and establish branches, pending shareholder approval [28] - Yong'an Pharmaceutical plans to reduce its holdings by up to 2.6323 million shares [29] - Zhujiang Co. received approval from the Shanghai Stock Exchange for a stock issuance to specific targets [31] Group 9 - Sanyangma's subsidiary signed a 120 million yuan procurement contract for sensor products [33] - Jintou City Development plans to purchase a villa property for approximately 7.1854 million yuan [35] - Yuanli Co. intends to acquire 100% of Tongsheng Co. through a combination of cash and stock issuance [36] Group 10 - Xin'an Century's controlling shareholder plans to reduce holdings by up to 2.22% of the company's shares [36] - Fute Technology plans to raise up to 528 million yuan through a private placement for various projects [36] - Helen Piano's actual controller is set to change, with stock resuming trading [37] Group 11 - Weiergao expects a net profit increase of 12.55% to 30.87% for the first half of the year [38] - Saiwei Microelectronics plans to transfer up to 18% of its shares through an agreement [40] - Yongli Co. intends to acquire a 22.75% stake in a subsidiary [42] Group 12 - ST Xiachuang plans to publicly transfer a 20% stake in Guangdong Yuweiji [43] - Dema Technology's shareholders plan to transfer 778.84 million shares through an inquiry [45] - Zhongshi Technology's shareholders plan to reduce holdings by up to 2.86% of the company's shares [46] Group 13 - Wufang Optoelectronics' controlling shareholder plans to reduce holdings by up to 0.93% of the company's shares [48] - Fusenmei's chairman has been detained, temporarily unable to fulfill his duties [49] - Reliable Co.'s shareholders plan to reduce holdings by a total of up to 2.63% of the company's shares [51] Group 14 - Gao Neng Environment plans to repurchase shares worth between 100 million and 150 million yuan [53]
东方海洋(002086) - 关于全资子公司取得医疗器械注册证的公告
2025-07-25 08:15
证券代码:002086 证券简称:东方海洋 公告编号:2025-039 山东东方海洋科技股份有限公司 关于全资子公司取得医疗器械注册证的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有 虚假记载、误导性陈述或者重大遗漏。 特别提示: 1. 艾维可生物科技有限公司今年对公司的业绩影响较小,本次获批上市的 叶酸(FA)测定试剂盒(磁微粒化学发光法)的投产及对公司业绩的后续影响 具有不确定性,请广大投资者注意投资风险。 2. 本次产品获证后还未投入生产,其实际销售情况受市场拓展力度及市场 实际需求等多重因素影响,目前尚无法预测上述获批产品对公司未来业绩的具体 影响,请广大投资者注意投资风险。 请广大投资者充分阅读本公告正文表述的相关风险事项,公司特别提示投资 者理性投资。 山东东方海洋科技股份有限公司(以下简称"公司")全资子公司艾维可生物 科技有限公司自主研发的叶酸(FA)测定试剂盒(磁微粒化学发光法)于近日 取得了山东省药品监督管理局的注册批准,获得医疗器械注册证(体外诊断试剂), 具体情况如下: 一、产品信息 | 产品名称 | 叶酸(FA)测定试剂盒(磁微粒化学发光法) | | | | | ...
东方海洋(002086) - 关于选举公司董事长(代行、法定代表人)、聘任公司总经理、财务总监、常务副总经理及调整董事会战略委员会、薪酬与考核委员会的公告
2025-07-15 10:00
证券代码:002086 证券简称:东方海洋 公告编号:2025-037 二、聘任公司总经理、财务总监 为加强公司管理、提升经营效率,根据《公司章程》规定,董事会已授权提名 委员会在总经理缺位期间代行相关提名职能,提名委员会、审计委员会已完成对刘 洪涛先生的任职资格审核,鉴于其在专业能力、行业经验、管理能力及职业素养等 方面均表现优异,符合公司总经理、财务总监的任职要求,公司董事会同意聘任刘 洪涛先生(简历附后)为公司总经理、财务总监。任期自董事会审议通过之日起至 公司第八届董事会届满之日止。 三、聘任公司常务副总经理 为满足公司长远发展需求,根据《公司章程》规定,经提名委员会完成对车志 远先生(简历附后)任职资格的审核后,公司董事会同意聘任其为公司常务副总经 理,其主要职责是协助总经理负责公司全面工作。任期自董事会审议通过之日起至 公司第八届董事会届满之日止。 四、调整公司第八届董事会战略委员会、薪酬与考核委员会 山东东方海洋科技股份有限公司 关于选举公司董事长(代行、法定代表人)、聘任公司总经 理、财务总监、常务副总经理及调整董事会战略委员会、薪酬 与考核委员会的公告 本公司及董事会全体成员保证公告内容的真 ...
东方海洋(002086) - 第八届董事会第二十二次会议决议公告
2025-07-15 10:00
证券代码:002086 证券简称:东方海洋 公告编号:2025-038 山东东方海洋科技股份有限公司 第八届董事会第二十二次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 山东东方海洋科技股份有限公司(以下简称"公司")第八届董事会第二十二次 会议于 2025 年 7 月 14 日以电话、邮件等形式通知全体董事,会议定于 2025 年 7 月 15 日以现场+线上方式召开,应参加董事 8 人,实际参加审议及表决董事 8 人。 因原董事长张乐先生辞去职务,经与各位董事沟通,董事共同推举董事吴俊先生主 持本次董事会。本次会议为紧急会议,召集人已在会议上就紧急会议的原因做出相 关说明,会议的召集、召开符合《公司法》和《公司章程》规定。会议以现场和线 上表决方式通过以下议案: 一、审议通过《关于选举公司董事长(代行、法定代表人)的议案》 根据《公司法》和《公司章程》的有关规定,公司董事长由公司董事会选举产 生。 与会董事以投票方式选举刘洪涛先生为公司第八届董事会董事长(代行、法定 代表人)。 表决结果:8 票同意,0 票反对,0 票弃权。 二、审议通过《 ...
东方海洋(002086) - 关于公司总经理辞职的公告
2025-07-14 10:45
本公司及董事会全体成员保证公告内容的真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 山东东方海洋科技股份有限公司(以下简称"公司")董事会于近日收到公司总 经理车志远先生的书面辞职报告。车志远先生因内部工作调整需要,申请辞去公司 总经理职务。依据《中华人民共和国公司法》《山东东方海洋科技股份有限公司章 程》的有关规定,车志远先生的辞职报告自送达公司董事会之日起生效。辞任后, 车志远先生仍在公司担任董事兼大健康事业部总裁,持续为公司的发展贡献力量。 截至本公告披露日,车志远先生未持有公司股份,不存在应当履行而未履行的 承诺事项。车志远先生的辞职不会对公司日常运营产生不利影响。公司董事会将按 照法定程序尽快完成公司新任总经理的聘任工作。为确保公司治理的连续性及各项 业务的正常有序开展,在公司聘任新任总经理之前,车志远先生将继续履行相关职 责。 证券代码:002086 证券简称:东方海洋 公告编号:2025-036 山东东方海洋科技股份有限公司 关于公司总经理辞职的公告 特此公告。 山东东方海洋科技股份有限公司 董事会 车志远先生任职总经理期间,始终秉持着对公司和股东负责的态度,努力推动 公司各项业务的发 ...